119 related articles for article (PubMed ID: 17047397)
1. Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas.
Soung YH; Lee JW; Nam SW; Lee JY; Yoo NJ; Lee SH
Oncology; 2006; 70(4):285-9. PubMed ID: 17047397
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
[TBL] [Abstract][Full Text] [Related]
3. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
Kim MS; Jeong EG; Yoo NJ; Lee SH
Br J Cancer; 2008 May; 98(9):1533-5. PubMed ID: 18392055
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations of the ERBB4 kinase domain in human cancers.
Soung YH; Lee JW; Kim SY; Wang YP; Jo KH; Moon SW; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
Int J Cancer; 2006 Mar; 118(6):1426-9. PubMed ID: 16187281
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of PIK3CA, JAK2, BRAF, FOXL2, IDH1, AKT1 and EZH2 oncogenes in sarcomas.
Je EM; An CH; Yoo NJ; Lee SH
APMIS; 2012 Aug; 120(8):635-9. PubMed ID: 22779686
[TBL] [Abstract][Full Text] [Related]
7. MEK1 and AKT2 mutations in Japanese lung cancer.
Sasaki H; Hikosaka Y; Kawano O; Moriyama S; Yano M; Fujii Y
J Thorac Oncol; 2010 May; 5(5):597-600. PubMed ID: 20354455
[TBL] [Abstract][Full Text] [Related]
8. Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms.
Nakayama K; Nakayama N; Kurman RJ; Cope L; Pohl G; Samuels Y; Velculescu VE; Wang TL; Shih IeM
Cancer Biol Ther; 2006 Jul; 5(7):779-85. PubMed ID: 16721043
[TBL] [Abstract][Full Text] [Related]
9. AKT1 and AKT2 mutations in lung cancer in a Japanese population.
Sasaki H; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Mol Med Rep; 2008; 1(5):663-6. PubMed ID: 21479466
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of PTPRT phosphatase domains in common human cancers.
Lee JW; Jeong EG; Lee SH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2007 Jan; 115(1):47-51. PubMed ID: 17223850
[TBL] [Abstract][Full Text] [Related]
11. A novel AKT3 mutation in melanoma tumours and cell lines.
Davies MA; Stemke-Hale K; Tellez C; Calderone TL; Deng W; Prieto VG; Lazar AJ; Gershenwald JE; Mills GB
Br J Cancer; 2008 Oct; 99(8):1265-8. PubMed ID: 18813315
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH.
Kirkegaard T; Witton CJ; Edwards J; Nielsen KV; Jensen LB; Campbell FM; Cooke TG; Bartlett JM
Histopathology; 2010 Jan; 56(2):203-11. PubMed ID: 20102399
[TBL] [Abstract][Full Text] [Related]
13. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.
Troxell ML; Levine J; Beadling C; Warrick A; Dunlap J; Presnell A; Patterson J; Shukla A; Olson NR; Heinrich MC; Corless CL
Mod Pathol; 2010 Jan; 23(1):27-37. PubMed ID: 19898424
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
17. Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas.
Dobashi Y; Tsubochi H; Matsubara H; Inoue J; Inazawa J; Endo S; Ooi A
Cancer Sci; 2015 Jun; 106(6):772-781. PubMed ID: 25855050
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations in AKT and its protein activation in human lung carcinomas.
Dobashi Y; Kimura M; Matsubara H; Endo S; Inazawa J; Ooi A
Hum Pathol; 2012 Dec; 43(12):2229-40. PubMed ID: 22748472
[TBL] [Abstract][Full Text] [Related]
19. PI3K/Akt pathway mutations in retinoblastoma.
Cohen Y; Merhavi-Shoham E; Avraham-Lubin BC; Savetsky M; Frenkel S; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5054-6. PubMed ID: 19420344
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer.
Zhang QY; Cheng WX; Li WM; Au W; Lu YY
Mutat Res; 2014 Nov; 769():108-12. PubMed ID: 25771729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
